Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223
Awaiting development [GID-HST10019] Expected publication date: TBC
Search results
12 results
-
-
Leriglitazone for treating andrenoleukodystrophy [ID3903]
Awaiting development [GID-HST10049] Expected publication date: TBC
-
OTL-101 for treating adenosine deaminase deficiency–severe combined immunodeficiency [ID1152]
Awaiting development [GID-HST10022] Expected publication date: TBC
-
Lonafarnib for treating progeria and progeroid laminopathies [ID3867]
Awaiting development [GID-HST10039] Expected publication date: TBC
-
VTS-270 for treating Niemann-Pick type C1 (ID1267)
Awaiting development [GID-HST10020] Expected publication date: TBC
-
Palovarotene for preventing heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID3739]
Awaiting development [GID-HST10032] Expected publication date: TBC
-
Advocacy services for adults with health and social care needs: draft scope consultation
We are listening to your views on this NICE guideline. Comments close 22 January 2021.
-
MRI-based technologies for assessing non-alcoholic fatty liver disease: diagnostics consultation
We are listening to your views on this Diagnostics guidance. Comments close 14 July 2022.
-
Thyroid cancer: assessment and management: draft guidance consultation
We are listening to your views on this NICE guideline. Comments close 4 August 2022.
-
Advocacy services for adults with health and social care needs: draft guidance consultation
We are listening to your views on this NICE guideline. Comments close 19 July 2022.
-
Cardiovascular disease: risk assessment and reduction, including lipid modification: call for evidence
We are listening to your views on this NICE guideline. Comments close 22 July 2022.
-
Asfotase alfa for treating paediatric-onset hypophosphatasia (review of HST6) [ID3927]
Awaiting development [GID-HST10046] Expected publication date: 15 December 2022